In vitro Degradation of β-amyloid Fibrils by Microbial Keratinase

Overview

Journal Alzheimers Dement (N Y)

Date 2019 Jun 14

PMID 31193333

Citations 6

Authors

Debananda S Ningthoujam

Saikat Mukherjee

Laishram Jaya Devi

Elangbam Shanta Singh

Keising Tamreihao

Rakhi Khunjamayum

Sumita Banerjee

Debashis Mukhopadhyay

Affiliations

Soon will be listed here.

Abstract

Introduction: Amyloid fibrils are misfolded, protease-resistant forms of normal proteins. They are infectious such as prions or noninfectious such as β-amyloid (Aβ) fibrils causing Alzheimer's disease (AD). Prions and amyloids are structurally similar, possessing cross β-pleated sheet-like structures. As microbial keratinase could degrade prions, we tested keratinase activity on Aβ fibrils.

Methods: Lysozyme treated with urea generates Aβ fibrils demonstrated by immunoblotting with anti-Aβ antibody, high-performance liquid chromatography, and Congo red absorption spectroscopy. Two keratinases, Ker1 and Ker2, were purified from an actinomycete Amycolatopsis sp. MBRL 40 and incubated with Aβ fibrils.

Results: Soluble Ker1 and Ker1 reconstituted on neutral/cationic liposomes degraded Aβ fibrils efficiently. Ker 2 was less potent.

Discussion: Drugs that target AD inhibit acetylcholinesterase or formation of Aβ fibrils and downstream effects. These drugs have side effects and do not benefit globally in cognition. Keratinases are novel molecules for drug development against AD.

Citing Articles

Natural serine proteases and their applications in combating amyloid formation.

Metkar S, Udayakumar S, Girigoswami A, Girigoswami K ADMET DMPK. 2024; 12(6):797-820.

PMID: 39713256 PMC: 11661804. DOI: 10.5599/admet.2551.

Metal Nanomaterials and Hydrolytic Enzyme-Based Formulations for Improved Antifungal Activity.

Lyagin I, Aslanli A, Domnin M, Stepanov N, Senko O, Maslova O Int J Mol Sci. 2023; 24(14).

PMID: 37511117 PMC: 10379199. DOI: 10.3390/ijms241411359.

Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression.

Naser S, Singh D, Preetam S, Kishore S, Kumar L, Nandi A Mater Today Bio. 2023; 21:100701.

PMID: 37415846 PMC: 10320624. DOI: 10.1016/j.mtbio.2023.100701.

Keratinases as Versatile Enzymatic Tools for Sustainable Development.

Sypka M, Jodlowska I, Bialkowska A Biomolecules. 2021; 11(12).

PMID: 34944542 PMC: 8699090. DOI: 10.3390/biom11121900.

Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.

Dhanavade M, Sonawane K 3 Biotech. 2020; 10(6):247.

PMID: 32411571 PMC: 7214582. DOI: 10.1007/s13205-020-02240-2.

References

Lansbury Jr P . Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A. 1999; 96(7):3342-4. PMC: 34271. DOI: 10.1073/pnas.96.7.3342. View

Krebs M, Wilkins D, Chung E, Pitkeathly M, Chamberlain A, Zurdo J . Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J Mol Biol. 2000; 300(3):541-9. DOI: 10.1006/jmbi.2000.3862. View

Williams C, Richter C, Mackenzie J, Shih J . Isolation, identification, and characterization of a feather-degrading bacterium. Appl Environ Microbiol. 1990; 56(6):1509-15. PMC: 184462. DOI: 10.1128/aem.56.6.1509-1515.1990. View

Muller-Hellwig S, Groschup M, Pichner R, Gareis M, Martlbauer E, Scherer S . Biochemical evidence for the proteolytic degradation of infectious prion protein PrPsc in hamster brain homogenates by foodborne bacteria. Syst Appl Microbiol. 2006; 29(2):165-71. DOI: 10.1016/j.syapm.2005.07.010. View

Irvine G, El-Agnaf O, Shankar G, Walsh D . Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med. 2008; 14(7-8):451-64. PMC: 2274891. DOI: 10.2119/2007-00100.Irvine. View

Serpell L . Alzheimer's amyloid fibrils: structure and assembly. Biochim Biophys Acta. 2000; 1502(1):16-30. DOI: 10.1016/s0925-4439(00)00029-6. View

Eanes E, Glenner G . X-ray diffraction studies on amyloid filaments. J Histochem Cytochem. 1968; 16(11):673-7. DOI: 10.1177/16.11.673. View

Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J . Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002; 416(6880):507-11. DOI: 10.1038/416507a. View

Yoshioka M, Miwa T, Horii H, Takata M, Yokoyama T, Nishizawa K . Characterization of a proteolytic enzyme derived from a Bacillus strain that effectively degrades prion protein. J Appl Microbiol. 2007; 102(2):509-15. DOI: 10.1111/j.1365-2672.2006.03080.x. View

10.

Bahuguna S, Kushwaha R . Hair perforation by keratinophilic fungi. Mycoses. 1989; 32(7):340-3. DOI: 10.1111/j.1439-0507.1989.tb02255.x. View

11.

Lin X, Lee C, Casale E, Shih J . Purification and Characterization of a Keratinase from a Feather-Degrading Bacillus licheniformis Strain. Appl Environ Microbiol. 1992; 58(10):3271-5. PMC: 183090. DOI: 10.1128/aem.58.10.3271-3275.1992. View

12.

Gibbs Jr C, Gajdusek D, LATARJET R . Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc Natl Acad Sci U S A. 1978; 75(12):6268-70. PMC: 393162. DOI: 10.1073/pnas.75.12.6268. View

13.

Der-Sarkissian A, Jao C, Chen J, Langen R . Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling. J Biol Chem. 2003; 278(39):37530-5. DOI: 10.1074/jbc.M305266200. View

14.

Bockle B, Galunsky B, Muller R . Characterization of a keratinolytic serine proteinase from Streptomyces pactum DSM 40530. Appl Environ Microbiol. 1995; 61(10):3705-10. PMC: 167669. DOI: 10.1128/aem.61.10.3705-3710.1995. View

15.

Kublanov I, Perevalova A, Slobodkina G, Lebedinsky A, Bidzhieva S, Kolganova T . Biodiversity of thermophilic prokaryotes with hydrolytic activities in hot springs of Uzon Caldera, Kamchatka (Russia). Appl Environ Microbiol. 2008; 75(1):286-91. PMC: 2612224. DOI: 10.1128/AEM.00607-08. View

16.

Glenner G, Ein D, Eanes E, Bladen H, Terry W, Page D . Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science. 1971; 174(4010):712-4. DOI: 10.1126/science.174.4010.712. View

17.

Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G . Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A. 1999; 96(7):3590-4. PMC: 22338. DOI: 10.1073/pnas.96.7.3590. View

18.

Krause D, Muller N . Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis. 2010; 2010. PMC: 2925207. DOI: 10.4061/2010/732806. View

19.

Sun X, Jin L, Ling P . Review of drugs for Alzheimer's disease. Drug Discov Ther. 2013; 6(6):285-90. View

20.

Dobson C . Protein misfolding, evolution and disease. Trends Biochem Sci. 1999; 24(9):329-32. DOI: 10.1016/s0968-0004(99)01445-0. View